QQ客服 官方微博 反馈留言

	Assessing the outcomes of everolimus on renal angiomyolipoma associated with tuberous sclerosis complex in China: a two years trial
	Cai, Yi; Guo, Hao; Wang, Wenda; Li, Hanzhong; Sun, Hao; Shi, Bing; Zhang, Yushi
	2018
卷号	13期号:1页码:43
关键词	Angiomyolipoma Tuberous sclerosis complex Everolimus Treatment outcome Safety
ISSN号	1750-1172
DOI	10.1186/s13023-018-0781-y
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6360164
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Cai, Yi,Guo, Hao,Wang, Wenda,et al. Assessing the outcomes of everolimus on renal angiomyolipoma associated with tuberous sclerosis complex in China: a two years trial[J],2018,13(1):43.
APA	Cai, Yi.,Guo, Hao.,Wang, Wenda.,Li, Hanzhong.,Sun, Hao.,...&Zhang, Yushi.(2018).Assessing the outcomes of everolimus on renal angiomyolipoma associated with tuberous sclerosis complex in China: a two years trial.,13(1),43.
MLA	Cai, Yi,et al."Assessing the outcomes of everolimus on renal angiomyolipoma associated with tuberous sclerosis complex in China: a two years trial".13.1(2018):43.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。